Valuation: Medpace Holdings, Inc.

Market Cap 17.33B 14.84B 13.89B 12.71B 23.86B 1,658B 24.17B 164B 63.98B 833B 65.06B 63.64B 2,754B P/E 2026 *
35.3x
P/E 2027 * 32.4x
Enterprise Value 16.52B 14.15B 13.24B 12.12B 22.75B 1,581B 23.05B 156B 61.02B 794B 62.05B 60.7B 2,627B EV / Sales 2026 *
5.79x
EV / Sales 2027 * 5.31x
Free-Float
80.09%
Yield 2026 *
-
Yield 2027 * -
1 day+1.32%
1 week+7.30%
Current month+7.56%
1 month+16.75%
3 months+44.33%
6 months+36.80%
Current year+10.52%
1 week 571.01
Extreme 571.01
629.69
1 month 563.45
Extreme 563.45
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
8/13/26 A Sell

Chief Executive Officer

-458 0.0016%
8/11/26 A Sell

Director

-1,140 0.0041%
8/11/26 A Sell

Chief Executive Officer

-17,610 0.0631%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%+7.30%+36.93%+152.36% 17.33B
+1.09%+5.26%+4.44%+26.03% 51.61B
-1.07%+2.82%+474.18%+601.24% 44.89B
+1.47%+9.79%+40.15%+21.21% 42.77B
+1.44%+7.77%+19.27%+90.94% 42.58B
-0.93%-4.33%+17.87%+51.96% 31.82B
-0.60%+1.93% - - 16.63B
+0.03%+3.41%+7.12%+35.49% 14.76B
+1.28%+5.41%+91.01%+46.93% 14.09B
-1.17%+5.57%-1.97%-30.78% 13.29B
Average +0.29%+4.55%+76.55%+110.60% 28.98B
Weighted average by Cap. +0.41%+4.76%+97.48%+139.80%

Financials

2026 *2027 *
Net sales 2.85B 2.44B 2.29B 2.09B 3.93B 273B 3.98B 27B 10.53B 137B 10.71B 10.48B 453B 3.03B 2.59B 2.43B 2.22B 4.17B 290B 4.22B 28.66B 11.18B 145B 11.37B 11.12B 481B
Net income 503M 430M 403M 369M 692M 48.08B 701M 4.76B 1.86B 24.15B 1.89B 1.85B 79.89B 547M 468M 438M 401M 753M 52.3B 763M 5.18B 2.02B 26.27B 2.05B 2.01B 86.89B
Net Debt -802M -687M -643M -589M -1.1B -76.76B -1.12B -7.6B -2.96B -38.56B -3.01B -2.95B -128B -1.25B -1.07B -1B -919M -1.72B -120B -1.75B -11.86B -4.62B -60.18B -4.7B -4.6B -199B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
21/08/26 $620.75 +1.32% 225,881
20/08/26 $612.64 +0.72% 254,525
19/08/26 $608.27 +3.04% 169,054
18/08/26 $590.30 -1.14% 131,427
17/08/26 $597.12 +3.22% 163,938
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
620.75USD
Average target price
581.83USD
Spread / Average Target
-6.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock